Biohaven Ltd. (BHVN)

NYSE

$12,13

$+0,34

(+2,84%)

Pre-Market

Biohaven Ltd. (BHVN) Live Price Chart

Last updated: ⁦2026-10-08 12:40:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Biohaven Ltd. (BHVN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $12,13, with a market capitalisation of $1,82B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7,48 to $18,57. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1,82B
Open	$11,90
Day's High	$152,56
Day's Low	$7,10
Previous Close	$11,88
Volume	33,62K
Average Volume	2,62M
P/E Ratio	--
52-Week High	$18,57
52-Week Low	$7,48
Dividend Yield	--
Earnings Date	--

Biohaven Ltd. (BHVN) Pre-Market Stock Price

Biohaven Ltd. (BHVN) is trading at $12,13 in pre-market trading as of 2026-10-08 12:39:00, up 2,06% ($0,24) from the previous close of $11,88

Pre-market trading shows how investors are pricing BHVN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Biohaven Ltd. (BHVN) 7-Day Stock Price Change

Over the past seven days, Biohaven Ltd. (BHVN) moved from $13,29 to $12,13, representing a decline of 8,77% ($1,16).

The stock traded between $11,85 and $13,63 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1,87 million shares, down versus the previous seven-day period, indicating lower trading activity.

BHVN 52-Week Price Position

Position in Range: 41,9%

52W Low$7,48

52W High$18,57

BHVN is currently trading at $12,13, placing it 41,9% of the way from its 52-week low of $7,48 to its 52-week high of $18,57. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Biohaven Ltd. (BHVN)?

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Biohaven Ltd. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	274
Exchange	NYSE
Company Website	https://www.biohaven.com

How to Buy Biohaven Ltd. (BHVN) Stock on MEXC

Eligible investors can buy real shares of Biohaven Ltd. (BHVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BHVN and Place Your Order

Open the RealStocks trading page and search for BHVN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Biohaven Ltd. (BHVN) stock price today?

Biohaven Ltd. (BHVN) is currently trading at $ 12,13, up 2,06% ($0,24) from the previous close of $ 11,88. Intraday prices update in real time during regular trading hours.

2.Is BHVN stock going up or down today?

As of 2026-10-08 12:39:00, BHVN is trading at $ 12,13, up 2,06% ($0,24) from its previous close of $ 11,88. The stock has traded between $ 7,10 and $ 152,56 during today’s regular session. Past price movements do not guarantee future results.

3.What is BHVN pre-market price?

As of 2026-10-08 12:39:00, BHVN is trading at $ 12,13 in pre-market trading, up 2,06% ($0,24) from the previous close of $ 11,88. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BHVN after-hours price?

As of 2026-10-08 12:39:00, BHVN is trading at $ 11,90 in after-hours trading, up 0,13% ($0,01) from the regular-session close of $ 11,88. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BHVN stock trading now?

BHVN trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BHVN sit relative to its 52-week high and low?

Over the past 52 weeks, BHVN has traded between a low of $ 7,48 and a high of $ 18,57. At $ 12,13, the stock is positioned 41,9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Biohaven Ltd. in?

Biohaven Ltd. (BHVN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Biohaven Ltd.'s market capitalisation and where is it listed?

Biohaven Ltd. is listed on the NYSE exchange with a market capitalisation of $ 1,82B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BHVN valued in terms of P/E ratio and EPS?

BHVN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3,89. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Biohaven Ltd. pay a dividend?

Biohaven Ltd. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.